Senores Pharmaceuticals Limited has informed the Exchange about Schedule of Analyst/Investor meeting on April 09, 2025.

Date: April 03, 2025

To, Sr. General Manager Listing Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400001

To, Sr. General Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, C-1, Block G Bandra Kurla Complex Bandra (E), Mumbai – 400 051

BSE Scrip Code: 544319

NSE Symbol: SENORES

Dear Sir/Madam,

Subject: Intimation of Schedule of Analyst / Investor meetings under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations 2015

Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended from time to time, we would like to inform you that the officials of the Company will be meeting Analysts / Investors (Participants) at the plant of its subsidiary at Chhatral, Gujarat and at the corporate office of the Company at Ahmedabad, Gujarat as per the details below:

Date and Time 09th April 2025 09:30 AM (IST) onwards

Nature of Meeting

Group Meeting

Discussions will be based on publicly available information. No unpublished price sensitive information (“UPSI”) is intended to be discussed during the meeting.

The investor presentation is available on the website of the Company viz. www.senorespharma.com.

Kindly note that changes in the above schedule may happen due to exigencies on the part of Participants / Company.

You are requested to take the same on record.

Thanking you.

For Senores Pharmaceuticals Limited

Vinay Kumar Mishra Company Secretary and Compliance Officer ICSI Membership No.: F11464

Senores Pharmaceuticals Limited  1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park,  Ambali Bopal Road, Ahmedabad‐380054, Gujarat, India

P: +91 79 2999 9857  |  E: info@senorespharma.com  W: www.senorespharma.com  |  CIN No.: U24290GJ2017PLC100263